综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Business

Private equity heads for healthcare firms at 4 sites

By Cai Xiao | China Daily | Updated: 2014-04-29 09:00

Domestic private equity firm China Science and Merchants Capital Management Ltd will invest at least 30 billion yuan ($4.8 billion) in the nation's health industry within five years, its chairman said.

The funds will go into companies in industrial bases in Tianjin, Shanghai, Guangzhou and Huzhou in Zhejiang province that were set up by CSM Group and local governments.

"The supply of healthcare products and equipment in China can't satisfy the huge demand of the public, so there are many investment opportunities," said Shan Xiangshuang, chairman of CSM Group.

CSM Group and Healthcare UK have signed a memorandum of understanding to bring advanced medical technology and products from Britain to China. Healthcare UK is a joint initiative of the Department of Health, UK Trade and Investment and NHS England.

The two parties will introduce British healthcare companies to the industrial bases and innovation platforms of CSM Group. There were 11 innovation platforms to support startup enterprises in 2013, and that number will be 50 by the end of this year.

With more than 60 billion yuan under management, CSM Group has invested more than 10 billion yuan in more than 100 health-related enterprises, of which Xiangxue Pharmaceutical Co Ltd and Ringpu Bio-Pharmacy Co Ltd have been listed.

In 2009, CSM Group and China Securities Co Ltd invested 64 million yuan in Xiangxue, which went public on the ChiNext board in 2010. Ringpu received 48 million yuan from CSM Group in 2008 and went public on the ChiNext board in 2010.

Shan said that CSM Group is also investing in early-stage companies in the medical sector. For example, Micro-Tech received 4 million yuan from CSM Group when it was just starting up. Now, it's preparing to go public.

Private equity firms are seeking opportunities in China's health market. For instance, the Carlyle Group LP is setting up its fourth Asia-focused buyout fund for healthcare and consumer investments and China is its largest destination.

Warburg Pincus LLC, Fosun Group and CDH Investments were also active in the sector in 2013.

caixiao@chinadaily.com.cn

 

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
武城县| 延川县| 陆丰市| 房产| 如皋市| 仙居县| 贺州市| 太谷县| 开封县| 集安市| 乌兰察布市| 云南省| 漯河市| 贡山| 阜康市| 华池县| 临汾市| 贵阳市| 镇康县| 井陉县| 闽侯县| 碌曲县| 崇信县| 原阳县| 监利县| 曲水县| 汪清县| 阳朔县| 鸡西市| 克拉玛依市| 百色市| 陕西省| 酒泉市| 田林县| 福清市| 镇原县| 泰州市| 阿拉善盟| 芒康县| 阿拉尔市| 阳江市|